Animal having modification in MGAT2 gene

Animal having modification in MGAT2 gene

It is an object to provide a gene-modified non-human animal having inactivated MGAT2 gene and a gene-modified non-human animal cell, which are useful for the search of the function of MGAT2 in vivo. It is another object to provide a method for screening of a compound capable of inhibiting the activi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Aragane, Katsumi, Ohbuchi, Katsuya, Tamai, Yoshitaka, Harada, Naomoto, Murai, Naomi, Ito, Yoshiki, Kusunoki, Jun, Tokushima, Yukina, Maruyama, Takaharu
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Aragane, Katsumi
Ohbuchi, Katsuya
Tamai, Yoshitaka
Harada, Naomoto
Murai, Naomi
Ito, Yoshiki
Kusunoki, Jun
Tokushima, Yukina
Maruyama, Takaharu
description It is an object to provide a gene-modified non-human animal having inactivated MGAT2 gene and a gene-modified non-human animal cell, which are useful for the search of the function of MGAT2 in vivo. It is another object to provide a method for screening of a compound capable of inhibiting the activity of MGAT2 and a compound capable of inhibiting the activity of MGAT2. It is further another object to provide a method for detecting a disease induced by abnormal lipid metabolism based on the expression level or activity of MGAT2. A method for screening of a compound by using a gene-modified non-human mammal having the artificially inhibited expression of MGAT2 gene and a cell thereof enable to prevent or treat a disease induced by abnormal lipid metabolism. Also a screening of a compound capable of inhibiting or enhancing the function of MGAT2 enables to prevent or treat a disease induced by abnormal lipid metabolism.
format Patent
fullrecord <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_08232447</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>08232447</sourcerecordid><originalsourceid>FETCH-uspatents_grants_082324473</originalsourceid><addsrcrecordid>eNrjZNBwzMvMTcxRyEgsy8xLV8jNT8lMy0xOLMnMz1PIzFPwdXcMMVJIT81L5WFgTUvMKU7lhdLcDApuriHOHrqlxQWJJal5JcXx6UWJIMrAwsjYyMTE3JgIJQBLlSgv</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Animal having modification in MGAT2 gene</title><source>USPTO Issued Patents</source><creator>Aragane, Katsumi ; Ohbuchi, Katsuya ; Tamai, Yoshitaka ; Harada, Naomoto ; Murai, Naomi ; Ito, Yoshiki ; Kusunoki, Jun ; Tokushima, Yukina ; Maruyama, Takaharu</creator><creatorcontrib>Aragane, Katsumi ; Ohbuchi, Katsuya ; Tamai, Yoshitaka ; Harada, Naomoto ; Murai, Naomi ; Ito, Yoshiki ; Kusunoki, Jun ; Tokushima, Yukina ; Maruyama, Takaharu ; MSD K.K</creatorcontrib><description>It is an object to provide a gene-modified non-human animal having inactivated MGAT2 gene and a gene-modified non-human animal cell, which are useful for the search of the function of MGAT2 in vivo. It is another object to provide a method for screening of a compound capable of inhibiting the activity of MGAT2 and a compound capable of inhibiting the activity of MGAT2. It is further another object to provide a method for detecting a disease induced by abnormal lipid metabolism based on the expression level or activity of MGAT2. A method for screening of a compound by using a gene-modified non-human mammal having the artificially inhibited expression of MGAT2 gene and a cell thereof enable to prevent or treat a disease induced by abnormal lipid metabolism. Also a screening of a compound capable of inhibiting or enhancing the function of MGAT2 enables to prevent or treat a disease induced by abnormal lipid metabolism.</description><language>eng</language><creationdate>2012</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/8232447$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,780,802,885,64039</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/8232447$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Aragane, Katsumi</creatorcontrib><creatorcontrib>Ohbuchi, Katsuya</creatorcontrib><creatorcontrib>Tamai, Yoshitaka</creatorcontrib><creatorcontrib>Harada, Naomoto</creatorcontrib><creatorcontrib>Murai, Naomi</creatorcontrib><creatorcontrib>Ito, Yoshiki</creatorcontrib><creatorcontrib>Kusunoki, Jun</creatorcontrib><creatorcontrib>Tokushima, Yukina</creatorcontrib><creatorcontrib>Maruyama, Takaharu</creatorcontrib><creatorcontrib>MSD K.K</creatorcontrib><title>Animal having modification in MGAT2 gene</title><description>It is an object to provide a gene-modified non-human animal having inactivated MGAT2 gene and a gene-modified non-human animal cell, which are useful for the search of the function of MGAT2 in vivo. It is another object to provide a method for screening of a compound capable of inhibiting the activity of MGAT2 and a compound capable of inhibiting the activity of MGAT2. It is further another object to provide a method for detecting a disease induced by abnormal lipid metabolism based on the expression level or activity of MGAT2. A method for screening of a compound by using a gene-modified non-human mammal having the artificially inhibited expression of MGAT2 gene and a cell thereof enable to prevent or treat a disease induced by abnormal lipid metabolism. Also a screening of a compound capable of inhibiting or enhancing the function of MGAT2 enables to prevent or treat a disease induced by abnormal lipid metabolism.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2012</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZNBwzMvMTcxRyEgsy8xLV8jNT8lMy0xOLMnMz1PIzFPwdXcMMVJIT81L5WFgTUvMKU7lhdLcDApuriHOHrqlxQWJJal5JcXx6UWJIMrAwsjYyMTE3JgIJQBLlSgv</recordid><startdate>20120731</startdate><enddate>20120731</enddate><creator>Aragane, Katsumi</creator><creator>Ohbuchi, Katsuya</creator><creator>Tamai, Yoshitaka</creator><creator>Harada, Naomoto</creator><creator>Murai, Naomi</creator><creator>Ito, Yoshiki</creator><creator>Kusunoki, Jun</creator><creator>Tokushima, Yukina</creator><creator>Maruyama, Takaharu</creator><scope>EFH</scope></search><sort><creationdate>20120731</creationdate><title>Animal having modification in MGAT2 gene</title><author>Aragane, Katsumi ; Ohbuchi, Katsuya ; Tamai, Yoshitaka ; Harada, Naomoto ; Murai, Naomi ; Ito, Yoshiki ; Kusunoki, Jun ; Tokushima, Yukina ; Maruyama, Takaharu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_082324473</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2012</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Aragane, Katsumi</creatorcontrib><creatorcontrib>Ohbuchi, Katsuya</creatorcontrib><creatorcontrib>Tamai, Yoshitaka</creatorcontrib><creatorcontrib>Harada, Naomoto</creatorcontrib><creatorcontrib>Murai, Naomi</creatorcontrib><creatorcontrib>Ito, Yoshiki</creatorcontrib><creatorcontrib>Kusunoki, Jun</creatorcontrib><creatorcontrib>Tokushima, Yukina</creatorcontrib><creatorcontrib>Maruyama, Takaharu</creatorcontrib><creatorcontrib>MSD K.K</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Aragane, Katsumi</au><au>Ohbuchi, Katsuya</au><au>Tamai, Yoshitaka</au><au>Harada, Naomoto</au><au>Murai, Naomi</au><au>Ito, Yoshiki</au><au>Kusunoki, Jun</au><au>Tokushima, Yukina</au><au>Maruyama, Takaharu</au><aucorp>MSD K.K</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Animal having modification in MGAT2 gene</title><date>2012-07-31</date><risdate>2012</risdate><abstract>It is an object to provide a gene-modified non-human animal having inactivated MGAT2 gene and a gene-modified non-human animal cell, which are useful for the search of the function of MGAT2 in vivo. It is another object to provide a method for screening of a compound capable of inhibiting the activity of MGAT2 and a compound capable of inhibiting the activity of MGAT2. It is further another object to provide a method for detecting a disease induced by abnormal lipid metabolism based on the expression level or activity of MGAT2. A method for screening of a compound by using a gene-modified non-human mammal having the artificially inhibited expression of MGAT2 gene and a cell thereof enable to prevent or treat a disease induced by abnormal lipid metabolism. Also a screening of a compound capable of inhibiting or enhancing the function of MGAT2 enables to prevent or treat a disease induced by abnormal lipid metabolism.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_uspatents_grants_08232447
source USPTO Issued Patents
title Animal having modification in MGAT2 gene
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T21%3A26%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Aragane,%20Katsumi&rft.aucorp=MSD%20K.K&rft.date=2012-07-31&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E08232447%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true